Data / Form D filings / BioMarck Pharmaceuticals Ltd
BioMarck Pharmaceuticals Ltd: Form D filings
BioMarck Pharmaceuticals Ltd, a pharmaceuticals company in Durham, NC, filed 4 Form D notices with the SEC between 2009 and 2017. The latest, on February 8, 2017, reports $751,320 sold of a $6 million offering to 8 investors.
Find out what BioMarck Pharmaceuticals Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2530 Meridian Parkway, Suite 300, Durham, NC, 27713
- Phone
- (844) 424-6627
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- North Carolina
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1318185
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 8, 2017 | New notice | $6,000,000 | $751,320 | $5,248,680 | 8 | Dec 30, 2016 | sec.gov |
| May 18, 2016 | New notice | $7,000,000 | $7,000,000 | $0 | 7 | Jul 16, 2013 | sec.gov |
| Aug 9, 2012 | New notice | $2,000,000 | $266,446 | $1,733,554 | 20 | Jul 31, 2012 | sec.gov |
| Aug 28, 2009 | Amendment | $7,500,000 | $7,500,000 | $0 | 115 | Nov 27, 2006 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Indu C. Parikh | Executive Officer | |
| Craig A. Collard | Director | |
| Rajin K. Ahuja | Director | |
| Kennedy C. O'Herron | Director | |
| Laura Calamos Nasir | Director | |
| Mohit K. Mehrotra | Director | |
| Thomas H. Roberg | Director | |
| Walker Calamos Long | Director | |
| Brian Dickson | Executive Officer | |
| Ashish C. Bhatia | Director | |
| Michael C. Enright | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Feb 6, 2017 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BioMarck Pharmaceuticals Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.